Fatty Liver Alliance advocates about the importance of 2 new NASH treatments soon to be approved. ICER welcomes public comments and discussion about new NASH drugs. NASH: Gastric bypass, diet, ...

Phase 1b study demonstrates that miricorilant, a selective cortisol modulator, effectively reduces liver fat, improves liver health and key metabolic and lipid measures and is well-tolerated Corcept ...

Here’s what you should know: 1. The office approved Immuron’s “Anti-LPS Enriched Immunoglobulin for Use in treatment and/or Prophylaxis of a Pathological Disorder” patent. 2. The patent is comprised ...

Host genetics and the gut microbiome, in a collaborative fashion, influence metabolic phenotypes. Recent studies suggest that the characteristics of the gut microbiota are altered in patients with ...

VANCOUVER, Washington, Sept. 04, 2019 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 ...